Cineole-containing composition, in particular pharmaceutical composition, preferably for topical, in particular nasal, preferably intranasal application, wherein the composition comprises in combination and in each case in effective, in particular pharmaceutically effective, amounts: (a) 1,8-cineole, wherein the 1,8-cineole is present as a pure substance, wherein the 1,8-cineole comprises a purity of at least 95 % by weight, based on the 1,8-cineole, and wherein the 1,8-cineole is free from other terpenes and wherein the composition contains component (a), based on the composition, in relative amounts in the range of 0.05 to 10 % by weight; (b) (b1) pantothenol, preferably dexpanthenol (D-pantothenol), or its physiologically acceptable esters and/or (b2) pantothenic acid or its physiologically acceptable salts, wherein the composition contains component (b) in relative amounts ranging from 0.01 to 10 % by weight of the composition; and (c) at least one emulsifier, wherein the composition contains component (c), based on the composition, in relative amounts in the range of 0.0001 to 10 % by weight and wherein component (c) is selected from the group of (i) fatty acids, fatty acid salts, fatty acid amides and fatty acid esters, (ii) optionally (poly)ethoxylated and/or hydrogenated castor oils, (iii) organic carboxylic acids and their salts and esters, (iv) organic betaines, (v) organic ammonium compounds, (vi) physiologically acceptable ionic or non-ionic surfactants, (vii) phospholipids, (viii) poloxamers (ethylene oxide/propylene oxide block copolymers), (ix) esters of polyhydric alcohols (polyalcohols), (x) glycols and their (poly)ethers and (poly)esters, and combinations of two or more of the above-mentioned connections; wherein the composition comprises a pH value in the range of 5.0 to 6.5 and wherein the composition does not contain any terpene other than 1,8-cineole. (a) 1,8-cineole, wherein the 1,8-cineole is present as a pure substance, wherein the 1,8-cineole comprises a purity of at least 95 % by weight, based on the 1,8-cineole, and wherein the 1,8-cineole is free from other terpenes and wherein the composition contains component (a), based on the composition, in relative amounts in the range of 0.05 to 10 % by weight; (b) (b1) pantothenol, preferably dexpanthenol (D-pantothenol), or its physiologically acceptable esters and/or (b2) pantothenic acid or its physiologically acceptable salts, wherein the composition contains component (b) in relative amounts ranging from 0.01 to 10 % by weight of the composition; and (b1) pantothenol, preferably dexpanthenol (D-pantothenol), or its physiologically acceptable esters and/or (b2) pantothenic acid or its physiologically acceptable salts, wherein the composition contains component (b) in relative amounts ranging from 0.01 to 10 % by weight of the composition; and (c) at least one emulsifier, wherein the composition contains component (c), based on the composition, in relative amounts in the range of 0.0001 to 10 % by weight and wherein component (c) is selected from the group of (i) fatty acids, fatty acid salts, fatty acid amides and fatty acid esters, (ii) optionally (poly)ethoxylated and/or hydrogenated castor oils, (iii) organic carboxylic acids and their salts and esters, (iv) organic betaines, (v) organic ammonium compounds, (vi) physiologically acceptable ionic or non-ionic surfactants, (vii) phospholipids, (viii) poloxamers (ethylene oxide/propylene oxide block copolymers), (ix) esters of polyhydric alcohols (polyalcohols), (x) glycols and their (poly)ethers and (poly)esters, and combinations of two or more of the above-mentioned connections; <EOS>